MedPath

ROSWELL PARK CANCER INSTITUTE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Glutamine in Treating Side Effects in Children Who Are Undergoing Stem Cell Transplantation

Phase 2
Completed
Conditions
Oral Complications
Unspecified Childhood Solid Tumor, Protocol Specific
First Posted Date
2004-06-17
Last Posted Date
2011-03-01
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
120
Registration Number
NCT00003898
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

🇺🇸

Simmons Cancer Center - Dallas, Dallas, Texas, United States

Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-06-11
Last Posted Date
2014-01-13
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
53
Registration Number
NCT00084708
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer

Phase 1
Completed
Conditions
Colorectal Cancer
Diarrhea
First Posted Date
2004-06-11
Last Posted Date
2013-01-31
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
2
Registration Number
NCT00084721
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Gemcitabine and Capecitabine in Treating Patients With Advanced and/or Inoperable Cholangiocarcinoma or Carcinoma of the Gallbladder

Phase 2
Completed
Conditions
Extrahepatic Bile Duct Cancer
Gallbladder Cancer
First Posted Date
2004-06-11
Last Posted Date
2012-01-12
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00084942
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid Tumors

Phase 1
Completed
Conditions
Unspecified Adult Solid Tumor, Protocol Specific
First Posted Date
2004-06-11
Last Posted Date
2023-08-04
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
61
Registration Number
NCT00084734
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate

Phase 2
Terminated
Conditions
Prostate Cancer
Interventions
Other: clinical observation
Dietary Supplement: calcitriol
First Posted Date
2004-06-11
Last Posted Date
2017-06-12
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
25
Registration Number
NCT00084864
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

BCG Plus Interferon Alfa 2b in Treating Patients With Bladder Cancer

Phase 2
Completed
Conditions
Bladder Cancer
First Posted Date
2004-05-21
Last Posted Date
2013-02-01
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00004122
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Gallium Nitrate in Treating Patients With AIDS-Related Non-Hodgkin's Lymphoma

Phase 2
Completed
Conditions
Lymphoma
First Posted Date
2004-05-20
Last Posted Date
2015-10-06
Lead Sponsor
Roswell Park Cancer Institute
Target Recruit Count
35
Registration Number
NCT00002578
Locations
🇺🇸

USC/Norris Comprehensive Cancer Center, Los Angeles, California, United States

🇺🇸

Albert Einstein Comprehensive Cancer Center, Bronx, New York, United States

🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Doxorubicin in Treating Patients With AIDS-Related Kaposi's Sarcoma

Phase 3
Completed
Conditions
Sarcoma
First Posted Date
2004-05-19
Last Posted Date
2013-02-04
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00002985
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

Diagnostic Procedure for Identifying Patients With Metastatic Colorectal Cancer

Not Applicable
Completed
Conditions
Colorectal Cancer
Metastatic Cancer
First Posted Date
2004-05-19
Last Posted Date
2013-02-05
Lead Sponsor
Roswell Park Cancer Institute
Registration Number
NCT00003186
Locations
🇺🇸

Roswell Park Cancer Institute, Buffalo, New York, United States

© Copyright 2025. All Rights Reserved by MedPath